PPMD — Protide Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Protide Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
1999 August 31st | 2000 August 31st | 2001 August 31st | 2002 August 31st | 2003 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.364 | -0.307 | -0.364 | -0.204 | -0.096 |
| Depreciation | |||||
| Changes in Working Capital | -0.005 | -0.013 | 0.035 | -0.019 | -0.011 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.319 | -0.283 | -0.296 | -0.191 | -0.076 |
| Capital Expenditures | -0.005 | -0.009 | 0 | 0 | -0.003 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.072 | -0.18 | 0.353 | 0.134 | -0.003 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.067 | -0.189 | 0.353 | 0.134 | -0.006 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.053 | 0.385 | 0.077 | 0.064 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.199 | -0.087 | 0.133 | 0.004 | -0.082 |